After failing to improve overall survival in unresectable metastatic bladder cancer in a phase 3 trial, this indication will be
Continue reading »
Home ยป carcinoma
Opdivo
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. OPDIVO CMI _V17.0 (op-DEE-voh) Nivolumab (nee-vol-u-mab) Consumer
Continue reading »
Proteogenomics offers insight to treating head and neck squamous cell carcinoma
Proteogenomic analysis may offer new insight into matching cancer patients with an effective therapy for their particular cancer. A new
Continue reading »
New combined treatment shows promise in hepatocellular carcinoma
Researchers from the Metabolism and Cancer group at the Bellvitge Biomedical Research Institute (IDIBELL), led by Dr. Sara Kozma, have
Continue reading »